Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0086 USD | 0.00% | 0.00% | -95.41% |
03-05 | Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc.. | CI |
02-16 | Peak Bio, Inc. announced that it has received $2.238 million in funding | CI |
Quotes 5-day view
Delayed Quote OTC Markets09/05/2024 | |
---|---|
Last | 0.0086 $ |
Volume | 1 422 |
Change | +∞% |
Opening | 0.01 |
High | 0.01 |
Low | 0.01 |
Performance
Current month | +1.18% | ||
1 month | +65.38% | ||
3 months | -77.19% | ||
6 months | -89.24% | ||
Current year | -95.41% | ||
1 year | -98.92% | ||
3 years | -99.91% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
0.00% | 0.00% | -95.41% | -98.92% | 195K | ||
-1.63% | -1.24% | -0.09% | +19.75% | 42.12B | ||
+0.34% | +0.57% | +49.62% | -6.44% | 42.05B | ||
-0.78% | -0.73% | -4.96% | +11.47% | 29.18B | ||
-0.35% | -0.21% | +11.18% | +49.40% | 26.02B | ||
-1.20% | -0.71% | -21.95% | -22.68% | 18.9B | ||
+1.16% | +3.58% | +8.61% | +2.15% | 13.21B | ||
+0.75% | +3.78% | +24.73% | +26.86% | 12.17B | ||
+0.01% | +0.80% | +28.31% | +88.00% | 12.16B | ||
-1.40% | -2.85% | -6.26% | +12.62% | 11.42B | ||
-0.65% | +4.77% | +2.05% | -1.40% | 10.14B | ||
-0.93% | +8.63% | +39.38% | -1.31% | 7.48B | ||
-1.58% | -1.63% | +13.79% | +92.73% | 6.57B | ||
+1.08% | +5.80% | +37.41% | +51.99% | 6.5B | ||
-1.89% | -4.52% | +3.67% | -36.86% | 6.41B | ||
-.--% | -.--% | - | - | 6.07B | ||
Average | -0.44% | +1.21% | +6.01% | +12.49% | ||
Weighted average by Cap. | -0.52% | +0.54% | +12.99% | +16.41% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -95.41% | ||
2023 | -95.53% | ||
2022 | -56.98% | ||
2021 | +0.62% |
- Stock Market
- Equities
- PKBO Stock
- Quotes Peak Bio, Inc.